Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s): VYYRF

Healthcare Drug Manufacturers - Specialty & Generic

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. It also owns a 100% interest in the Frances Creek barium sulfate (barite) project, which is a rare grade mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.

TSXV:VM - Post by User

Voyageur Pharmaceuticals Ltd > CEO Interview

<< Previous

Bullboard Posts

Next >>

Comment by lscfaon Mar 07, 2021 7:28pm

158 Views

Post# 32740333

RE:CEO Interview

Sounds like co. can sell to some international markets with a Health Canada approval....

SH: How do you plan on generating cashflow?

BW: Well, it's all about getting barium sulfate into the bottle and out to market. So we're starting with third-party minerals. We're importing those from China. We have inventory on the ground, we're ready to move, put those into bottles as soon as we get all our formulation work done, we have some testing work to do with ABL, get the whole manufacturing chain in place. And that'll take us a few months and then we're going to go out and hit the market in Canada, and also look at international markets, and after FDA applications it's the doors wide open, and worldwide we're going international on our sales long-term.